KORU Medical Systems price to free cash flow KRMD
Market value divided by free cash flow over the last twelve months, since 2012.
- Today, Oct 23, 2026
- 188×
- 10-year median
- 93.4×
- Against its 10-year history
- 57th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 12.5× to 359×
- Peer median
- 11.0×
KORU Medical Systems' price to free cash flow is 188× as of Oct 23, 2026.
That is above its ten-year median of 93.4×, close to the middle of its last ten years.
Over that time it ranged from 12.5× in Dec 2016 to 359× in May 2020.
The median for 10 medical instruments and supplies stocks of a similar size is 11.0×.
Price to free cash flow over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 188× | 176× | 211× |
| 2025 | n/m a value too high to mean anything | ||
| 2024 | n/m a value too high to mean anything | ||
| 2023 | n/m a value too high to mean anything | ||
| 2022 | n/m a value too high to mean anything | ||
| 2021 | 210× | 194× | 289× |
| 2020 | 315× | 43.5× | 359× |
| 2019 | 50.1× | 47.8× | 52.5× |
| 2018 | n/m a value too high to mean anything | ||
| 2017 | 31.2× | 26.5× | 33.2× |
| 2016 | 16.2× | 6.7× | 17.4× |
| 2015 | 20.6× | 13.1× | 107× |
| 2014 | 68.3× | 8.0× | 71.7× |
| 2013 | 12.1× | 11.5× | 41.1× |
| 2012 | 44.0× | 42.2× | 49.9× |
Against its peers
Companies in Medical - Instruments & Supplies nearest KORU Medical Systems' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| KRMDKORU Medical Systems | 188× |
| PDEXPro DEX | 29.5× |
| KEQUKewaunee Scientific | 8.7× |
| UTMDUtah Medical Products | 20.6× |
| INFUInfuSystem | 12.1× |
| APTAlpha Pro Tech | 9.7× |
| EMBCEmbecta | 2.3× |
| TCMDTactile Systems Technology | 20.0× |
| NEPHNephros | n/m |
| MDXGMimedx | n/m |
| MOVMovado | 9.8× |
| Peer median | 11.0× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on KORU Medical Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.